Link to this page
National Cancer Institute Thesaurus
| Preferred Name | Fludarabine | |
| Synonyms |
FLUDARABINE Fludarabine 9-Beta-D-arabinofuranosyl-2-fluoroadenine fludarabine 2-Fluorovidarabine 9-Beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 2-Fluoro-9-beta-arabinofuranosyladenine Fluradosa |
|
| Definitions |
A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1094 |
|
| Accepted_Therapeutic_Use_For |
Acute nonlymphocytic leukemia; Chronic lymphocytic leukemia; Indolent Non - Hodkins Lymphoma
|
|
| ALT_DEFINITION |
The active ingredient in a drug used to treat B-cell chronic lymphocytic leukemia (CLL) that has not responded to treatment with other anticancer drugs or that has gotten worse. Fludarabine blocks cells from making DNA and may kill cancer cells. It is a type of purine antagonist and a type of ribonucleotide reductase inhibitor.
|
|
| CAS_Registry |
21679-14-1
|
|
| Chemical_Formula |
C10H12FN5O4
|
|
| code |
C1094
|
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173234 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C186328 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C186327 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C174019 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C186341 |
|
| Contributing_Source |
FDA GDC HemOnc PCDC
|
|
| DEFINITION |
A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth. (NCI04)
|
|
| FDA_UNII_Code |
P2K93U8740
|
|
| FULL_SYN |
FLUDARABINE Fludarabine 9-Beta-D-arabinofuranosyl-2-fluoroadenine fludarabine 2-Fluorovidarabine 9-Beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 2-Fluoro-9-beta-arabinofuranosyladenine Fluradosa
|
|
| Has_Salt_Form | ||
| Is_PCDC_AML_Authorized_Value_For_Variable | ||
| Is_Value_For_GDC_Property | ||
| label |
Fludarabine
|
|
| Legacy Concept Name |
Fludarabine
|
|
| Maps_To |
Fludarabine
|
|
| NSC Number |
118218
|
|
| Preferred_Name |
Fludarabine
|
|
| prefixIRI |
Thesaurus:C1094
|
|
| Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide
|
|
| UMLS_CUI |
C0059985
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |